A differential role for interleukin-6 and tumor necrosis factor-α in schizophrenia?

[1]  R. Willette,et al.  Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. , 1997, Stroke.

[2]  J. Mege,et al.  Elevated circulating levels of IL-6 in schizophrenia , 1996, Schizophrenia Research.

[3]  R. Wyatt,et al.  Serum cytokine concentrations in patients with schizophrenia , 1996, Schizophrenia Research.

[4]  L. Peltonen.  All out for chromosome six , 1995, Nature.

[5]  W. Savino,et al.  Immune-neuroendocrine interactions. , 1995, Immunology today.

[6]  J. Calabrese,et al.  Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. , 1995, Journal of psychiatric research.

[7]  P. Jungers,et al.  Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes. , 1995, Journal of immunology.

[8]  C. Dinarello,et al.  The biological properties of interleukin-1. , 1994, European cytokine network.

[9]  P. Pozzilli,et al.  Cytokines and autoimmunity , 1994, Clinical and experimental immunology.

[10]  R. Rimón,et al.  Plasma levels of interleukin-1β and interleukin-6 in schizophrenia, other psychoses, and affective disorders , 1994, Schizophrenia Research.

[11]  B. Rabin,et al.  Serum interleukin-6 concentration in schizophrenia: Elevation associated with duration of illness , 1994, Psychiatry Research.

[12]  H. Meltzer,et al.  Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression , 1993, Psychiatry Research.

[13]  L. Punzi,et al.  Soluble tumor necrosis factor receptors in human inflammatory synovial fluids. , 1993, Arthritis and rheumatism.

[14]  R. S. Smith.  A comprehensive macrophage-T-lymphocyte theory of schizophrenia. , 1992, Medical hypotheses.

[15]  P. Suter,et al.  Imbalance between tumour necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia. The J5 Study Group. , 1992, Immunology.

[16]  R. S. Smith.  Is schizophrenia caused by excessive production of interleukin-2 and interleukin-2 receptors by gastrointestinal lymphocytes? , 1991, Medical hypotheses.

[17]  L. Opler,et al.  The Positive and Negative Syndrome Scale (PANSS): Rationale and Standardisation , 1989, British Journal of Psychiatry.

[18]  S. Paul,et al.  Increased numbers of CD5+ B lymphocytes in schizophrenic patients. , 1989, Archives of General Psychiatry.

[19]  S. Belle,et al.  Decreased interleukin-2 production in schizophrenic patients , 1989, Biological Psychiatry.

[20]  H. Lôo,et al.  Aberrant T cell-mediated immunity in untreated schizophrenic patients: deficient interleukin-2 production. , 1989, The American journal of psychiatry.

[21]  B. Rabin,et al.  Increased serum interleukin 2 receptor concentration in schizophrenic and brain-damaged subjects. , 1989, Archives of general psychiatry.

[22]  S. Paul,et al.  Elevated levels of soluble interleukin 2 receptors in schizophrenia. , 1989, Archives of general psychiatry.

[23]  R. Ganguli,et al.  Clinical and Laboratory Evidence of Autoimmunity in Acute Schizophrenia , 1987, Annals of the New York Academy of Sciences.

[24]  L. DeLisi,et al.  An analysis of lymphocyte subpopulations in schizophrenic patients. , 1982, Biological psychiatry.

[25]  R. Fieve,et al.  The relationship of atypical lymphocytes, phenothiazines, and schizophrenia. , 1966, Archives of general psychiatry.

[26]  L. Bruce,et al.  Clinical and Experimental Observations on Katatonia , 1903 .

[27]  Dc Washington.  Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. , 1994 .

[28]  D. Kirch.  Infection and autoimmunity as etiologic factors in schizophrenia: a review and reappraisal. , 1993, Schizophrenia bulletin.

[29]  S. Kanba,et al.  Serum interleukin-6 in schizophrenic patients. , 1991, Life sciences.